Skip to Content

Notice

Center for Substance Abuse Prevention; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to Public Law 92-463, notice is hereby given that the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet in person and via web conference on March 20, 2018, from 10:00 a.m. to 3:00 p.m. EDT, and March 21, 2018 from 10:00 a.m. to 2:00 p.m. EDT.

The Board will meet in open session on March 20, 2018, from 10:00 a.m. to 1:00 p.m., to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, hear from our federal partners and early observations from the synthetic opioid testing implementation, review research data on a marijuana vaping study, and a brief update on the Medical Review Officer (MRO) Guidance Manual and 2018 MRO Guidance Manual Case Studies.

The board will meet in closed session on March 20, 2018, from 2:00 p.m. to 3:00 p.m. EDT and on March 21, 2018, from 10:00 a.m. to 2:00 p.m. EDT to discuss the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (oral fluid), and the Mandatory Guidelines for Federal Workplace Drug Testing Programs (hair specimen). Therefore, these portions of the meeting are closed to the public as determined by the Assistant Secretary, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d).

Meeting registration information can be completed at http://snacregister.samhsa.gov/​MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, http://www.samhsa.gov/​about-us/​advisory-councils/​drug-testing-advisory-board-dtab or by contacting the Designated Federal Officer, CAPT Sean J. Belouin, USPHS.

Committee Name: Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Prevention Drug Testing Advisory Board.

Dates/Time/Type:

March 20, 2018, from 10:00 a.m. to 1:00 p.m., EDT: Open.

March 20, 2018, from 2:00 p.m. to 3:00 p.m., EDT: Closed.

March 21, 2018, from 10:00 a.m. to 2:00 p.m., EDT: Closed.

Place: Parklawn Building, Room 5A03, 5600 Fishers Lane, Rockville, Maryland 20857.

Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and Regulatory Policy Advisor, Division of Workplace Programs, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276-2600, Email: sean.belouin@samhsa.hhs.gov.

Start Signature

Charles LoDico,

Chemist.

End Signature End Preamble

[FR Doc. 2018-03897 Filed 2-26-18; 8:45 am]

BILLING CODE 4162-20-P